Arnnon Geshuri - Mar 25, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Mar 25, 2024
Transactions value $
-$92,475
Form type
4
Date filed
3/26/2024, 04:05 PM
Previous filing
Mar 20, 2024
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $20.5K +7.5K +19.5% $2.73 46K Mar 25, 2024 Direct F1
transaction TDOC Common Stock Sale -$113K -7.5K -16.31% $15.06 38.5K Mar 25, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -7.5K -3.29% $0.00 220K Mar 25, 2024 Common Stock 7.5K $2.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 8, 2023.
F2 One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter.